Valuation: Heron Neutron Medical Corp.

Capitalization 65.72B 2.08B 1.78B 1.65B 1.55B 2.87B 190B 3.07B 18.93B 7.49B 89.98B 7.79B 7.63B 329B P/E ratio 2025 *
-109x
P/E ratio 2026 * -165x
Enterprise value 65.72B 2.08B 1.78B 1.65B 1.55B 2.87B 190B 3.07B 18.93B 7.49B 89.98B 7.79B 7.63B 329B EV / Sales 2025 *
7,499x
EV / Sales 2026 * 3,057x
Free-Float
45.79%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-5.72%
1 week-1.98%
Current month-6.98%
1 month-22.79%
3 months-41.83%
6 months-56.30%
Current year-6.98%
More quotes
1 week 416.5
Extreme 416.5
459.5
1 month 378
Extreme 378
527
Current year 378
Extreme 378
469
1 year 200
Extreme 200
984
3 years 122
Extreme 122
984
5 years 122
Extreme 122
984
10 years 122
Extreme 122
984
More quotes
Manager TitleAgeSince
Chief Executive Officer - 09/09/2020
Chief Tech/Sci/R&D Officer - 29/02/2024
Treasurer - 30/04/2024
Director TitleAgeSince
Chairman - 24/07/2017
Director/Board Member - 24/07/2017
Director/Board Member - 24/07/2017
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-5.72%-1.98%+108.96% - 2.2B
+2.79%+2.33%+11.04%+7.18% 233B
-0.71%-4.22%-13.31%+103.95% 187B
+3.29%+1.72%-0.84%-11.79% 166B
+0.56%-2.17%-9.12%+101.03% 135B
-2.00%-6.65%-16.26%-9.37% 58.28B
+2.01%+2.45%+21.68%+7.38% 48.43B
+2.90%-4.21%-8.39%-10.36% 38.51B
+2.41%-0.09%+4.64%+10.46% 36.88B
+2.88%-4.92%-7.14%+21.46% 35.91B
Average +0.35%-3.88%+9.12%+24.44% 94.05B
Weighted average by Cap. +1.08%-3.65%-1.45%+35.58%
See all sector performances

Financials

2025 *2026 *
Net sales 8.76M 277K 237K 220K 206K 383K 25.39M 410K 2.52M 999K 12M 1.04M 1.02M 43.83M 21.5M 680K 581K 540K 506K 939K 62.28M 1.01M 6.19M 2.45M 29.43M 2.55M 2.5M 108M
Net income -604M -19.1M -16.33M -15.16M -14.22M -26.38M -1.75B -28.24M -174M -68.85M -827M -71.63M -70.16M -3.02B -398M -12.59M -10.76M -9.99M -9.37M -17.38M -1.15B -18.61M -115M -45.37M -545M -47.2M -46.23M -1.99B
Net Debt - -
More financial data * Estimated data
Logo Heron Neutron Medical Corp.
Heron Neutron Medical Corp is a Taiwan-based company mainly engaged in the medical-related businesses. The main products and services include accelerator-based boron neutron capture therapy (AB-BNCT) medical equipment, boron neutron capture therapy detection and treatment drugs, boron neutron capture therapy medical equipment repair and maintenance, and radiation shielding planning services. The Company also provides ACSI cyclotron accelerators. The Company distributes products and services in the Taiwanese market, the Asia-Pacific market, and the European and American markets.
Employees
60
More about the company
Date Price Change Volume
21/01/26 420.00 NT$ -5.72% 506,534
20/01/26 445.50 NT$ +0.22% 560,747
19/01/26 444.50 NT$ +3.61% 940,677
16/01/26 429.00 NT$ -0.23% 798,326
15/01/26 430.00 NT$ +0.35% 1,111,049

End-of-day quote Taiwan S.E., January 20, 2026

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
420.00TWD
Average target price
1,203.33TWD
Spread / Average Target
+186.51%
Consensus

Annual profits - Rate of surprise